Literature DB >> 9551949

Critical role of NK1+ T cells in IL-12-induced immune responses in vivo.

T Kawamura1, K Takeda, S K Mendiratta, H Kawamura, L Van Kaer, H Yagita, T Abo, K Okumura.   

Abstract

CD1-dependent NK1+ T cells rapidly produce IL-4 upon stimulation through the TCR. These cells may therefore play an important role in the initiation of Th2 responses. Here, we show that NK1+ T cells constitutively express receptors for IL-12 and IFN-gamma, and that IL-12 induces production of perforin in these cells. Moreover, while IL-12 induces high levels of IFN-gamma and cytotoxic activity of hepatic or splenic mononuclear cells against tumor cells, this effect of IL-12 is significantly reduced in CD1-deficient mice with impaired NK1+ T cells development. These results indicate that NK1+ T cells play a critical role in IL-12-induced production of IFN-gamma to initiate Th1 immune responses and as IL-12-induced cytotoxic effector cells to initiate antitumor immunity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551949

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Natural T cells: cranking up the immune system by prompt cytokine secretion.

Authors:  S Joyce
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 2.  Educating T cells: early events in the differentiation and commitment of cytokine-producing CD4+ and CD8+ T cells.

Authors:  A Kelso
Journal:  Springer Semin Immunopathol       Date:  1999

Review 3.  Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.

Authors:  Aleksandar K Stanic; Jang-June Park; Sebastian Joyce
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

4.  CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion.

Authors:  Silke Gillessen; Yuri N Naumov; Edward E S Nieuwenhuis; Mark A Exley; Frederick S Lee; Nicolas Mach; Andrew D Luster; Richard S Blumberg; Masaru Taniguchi; Steven P Balk; Jack L Strominger; Glenn Dranoff; S Brian Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-07       Impact factor: 11.205

5.  Effects of alpha-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Valpha24+ Vbeta11+ T cells.

Authors:  H J Van Der Vliet; N Nishi; Y Koezuka; M A Peyrat; B M Von Blomberg; A J Van Den Eertwegh; H M Pinedo; G Giaccone; R J Scheper
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

6.  Intensive generation of NK1.1- extrathymic T cells in the liver by injection of bone marrow cells isolated from mice with a mutation of polymorphic major histocompatibility complex antigens.

Authors:  R C Halder; T Kawamura; M Bannai; H Watanabe; H Kawamura; M K Mannoor; S R Morshed; T Abo
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

7.  Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors.

Authors:  Cynthia A Ellison; Masaru Taniguchi; Jacqie M M Fischer; Kent T Hayglass; John G Gartner
Journal:  Immunology       Date:  2006-07-26       Impact factor: 7.397

8.  iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo .

Authors:  Hamid Bassiri; Rupali Das; Peng Guan; David M Barrett; Patrick J Brennan; Pinaki P Banerjee; Susan J Wiener; Jordan S Orange; Michael B Brenner; Stephan A Grupp; Kim E Nichols
Journal:  Cancer Immunol Res       Date:  2014-01       Impact factor: 11.151

Review 9.  NKT cells in sepsis.

Authors:  Briana Leung; Hobart W Harris
Journal:  Clin Dev Immunol       Date:  2010-10-04

10.  Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.

Authors:  Yoshiko Habu; Takefumi Uchida; Takuo Inui; Hiroyuki Nakashima; Masashi Fukasawa; Shuhji Seki
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.